Tech Optimist Episode #50: Suing the FDA
GLP-1 Makers using Chevron ruling to take on the FDA?
Tech Optimist, presented by Alumni Ventures, focuses on the intersection of technology, entrepreneurship, and innovation. We are passionate about technology and its potential to drive positive change. We explore our lane through with founders, investors, and futurists; discussions of new innovations; and reviews of trends in technology and venture capital. Subscribe Here »
In our latest Three Breakthroughs segment, Alumni Ventures Founder and CEO Mike Collins and Partner Michael Peri dive into three groundbreaking topics that are shaping our present and future:
- The contentious issue of litigation against the FDA, sparked by disagreements over drug classifications — a debate that could redefine pharmaceutical regulations.
- The role of AI in refining and implementing climate policies, highlighting its potential to sift through vast amounts of data to pinpoint effective strategies.
- The complex relationship between technology and mental health, discussing both the challenges and opportunities it presents in combating loneliness and fostering connections.
Listen Here »
Alumni Ventures offers accredited individuals access to professional-grade venture capital, a key asset class missing from the portfolios of many sophisticated investors. Since 2014, AV has raised $1.3+ billion from 10,000+ investors and backed 1,400+ unique portfolio companies. AV is a top 20 venture firm in North America according to CB Insights, as well as the #1 most active venture firm in the U.S., and #3 most active in the world, according to PitchBook’s 2022 and 2023 rankings. AV has won awards from Inc. Magazine, Fast Company, Benzinga, and the US FinTech Awards.
